About
GPCR Therapeutics USA, Inc. is developing pharmaceuticals based on the cutting-edge knowledge of G Protein-Coupled Receptors (GPCRs). Our company is focusing on discovering GPCR heterodimers and developing drugs targeting disease-specific heterodimers in cancer.